Dr. Osguthorpe:
CBD is flooding the marketplace in every product imaginable,
from mascara to doggy treats. The trouble is when people
take CBD to help them with health problems, they require
really high doses — so high, in fact, that the price point
becomes unaffordable for most people.
Dr. Hill:
On top of that, we are seeing a lot of inconsistencies in the
amount of CBD that’s available in some of these products. Is
there purity in these products?
Dr. Osguthorpe:
The trouble with CBD is that the hemp industry, where CBD
comes from, is not well regulated. Products are not checked
for purity, so the amount of CBD within those products can
be highly variable. Because of the dissonance between the
federal and state statutes around CBD, it’s not a good time
for us as a company to enter that arena.
Dr. Hill:
We’re not saying that CBD has no value — it just requires a
lot to be potent and pure. Let’s explain the endocannabinoid
system, which CBD affects, for everyone to understand.
Dr. Osguthorpe:
The endocannabinoid system controls a host of things in our
bodies — eat, sleep, forget, relax — through receptors called
endocannabinoids. Plants make chemicals that interact with
our body’s receptors called phytocannabinoids. CBD is one
those plant phytocannabinoids, and beta caryophyllene is
another. You regulate the endocannabinoid system either
up or down with how you bind to those receptors: beta
caryophyllene is a direct binder to the system, and CBD is
an indirect binder. Copaiba has substantial amounts of the
phytocannabinoid beta caryophyllene. The potency you can
obtain through a purified product like Copaiba with beta
caryophyllene is quite high because it’s a direct binder to the
body’s receptors.
Binding at the receptor level is really important, but what
matters is how you change cellular functions like DNA proteins
and enzymes. CBD affects your endocannabinoid system, but
it actually affects it indirectly and by a different mechanism
than most cannabinoids. CBD acts on an enzyme called Fatty
Acid Amide Hydrolase (FAAH). FAAH breaks down anandamide,
an endocannabinoid that activates the CB1 receptors and
produces a euphoric feeling. CBD slows down FAAH’s activity,
which leads to increased levels of anandamide, or too much
euphoria, in the body.
Dr. Hill:
Copaiba is more diverse; it’s not just a phytocannabinoid or
beta caryophyllene. There are many molecules within the
essential oils with plant chemistry that we know has other
benefits than on just the EC system. Unlike CBD, Copaiba has
other benefits outside of the endocannabinoid system.
We’re confident we have potency and purity in Copaiba. We
have looked at the research to know that very small dosage
amounts can still create the benefits and effects we’re looking
for. Sometimes a bottle of CBD sells for hundreds of dollars,
and the amount that I would have to consume is exponentially
higher than consuming something like Copaiba that has a
higher chemical makeup. From Copaiba I get greater benefit,
greater efficacy, and a much higher value.
Dr. Osguthorpe:
The foundation of what dōTERRA does is price, purity, potency,
and pathway. Based on these four Ps, I think Copaiba will
define itself in the marketplace quite nicely over time.
Benefits of Copaiba
• Promotes clear, smooth skin
• Stimulating, woody and spicy
fragrance known to help
soothe emotions
• Provides a soothing massage
when combined with
Fractionated Coconut Oil
• Enhances the appearance of
healthy-looking skin
doterra.com / 9